A practical reference on LKKTETQ: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-05-05. Anything still debated is marked as such rather than presented as settled.
Once dissolved, the peptide is far less stable than the dry powder. Aqueous solutions are subject to hydrolysis, oxidation at susceptible residues and gradual loss of material through adsorption onto glass and plastic surfaces. Terminal glutamine can cyclise under some conditions, producing a related species that complicates purity assessment. Dilute solutions tend to lose a larger fraction of material to surfaces than concentrated ones. Buffers, pH and ionic strength all influence the rate of change, so stability figures are only meaningful when those parameters are stated alongside the storage interval.
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Lyophilised cake or powder |
| Solubility class | Freely soluble in water | Aqueous buffers also used |
| Typical storage temperature | About -20 degrees Celsius | Dry, sealed and protected from light |
| Typical analytical method | Reversed-phase HPLC or LC-MS/MS | Used for purity, identity and quantification |
| Common synonyms | Thymosin beta-4 fragment | Also listed under fragment-based descriptions |
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
== Medical uses == Gallium (68Ga) gozetotide is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer. Ga 68 PSMA-11 injections are used for PET imaging of prostate-specific membrane antigen (PSMA) positive lesions in males with prostate cancer. It can be given for the patients with suspected metastasis, and the candidates with initial definitive therapy.
The Nintendo Switch version received "mixed or average" reviews according to review aggregator Metacritic. Daniel Tack of Game Informer praised the game's music, mechanics, and narrative, but did not give the game an official rating. Alice Bell of Rock Paper Shotgun described the game as "extremely odd" and "extremely terrifying". Russell Troxel praised the game, stating that it is "worth every penny they’re asking". On consoles, the game was generally positively noted for its narrative and voice acting, but was criticized for its performance issues, confusing gameplay and sluggish interface. Shaun Musgrave, in his review on TouchArcade, said the Nintendo Switch version has "fantastic characters and sublime music" with a new Japanese voiceover option. He found the console version's stability issues a downgrade from the PC counterpart, which he noted was already poorly optimized, and commented its text size is too small to be playable. Charlie Wacholz of Nintendo Life gave it a negative review, criticizing confusing gameplay, clunky menus, and performance issues. He found the game difficult to play in longer sessions due to its text being almost illegible on screen, and compare its trial-and-error gameplay to "a mild bout of Stockholm Syndrome". He scored it a 4 out of 10. Kazuma Hashimoto from Siliconera left a mixed review, calling its voice acting "top notch" and enjoying its turn-based battle system for its complexity.
=== Biology === The dragon's blood tree usually produces its flowers around March, though flowering does vary with location. The flowers tend to grow at the end of the branches. The plants have inflorescences and bear small clusters of fragrant, white, or green flowers. The fruits take five months to completely mature. The fruits are described as a fleshy berry, which changes from green to black as it gradually ripens. The fleshy berry fruit ends up being an orange-red color that contains one to three seeds. The berries are usually eaten and dispersed by birds and other animals. The tree's umbrella-shaped crown is adapted to arid conditions and is influenced by atmospheric moisture. Its leaves are scleromorphic, helping to prevent excessive water loss. The dragon's blood tree's distinctive umbrella shape is made possible by its unusual growth pattern. Unlike most monocots, Dracaena cinnabari undergoes secondary growth—a rare ability that allows its trunk to thicken over time. While its stem develops growth ring-like zones, these do not reliably indicate age since they form from irregular vascular bundle patterns rather than seasonal growth cycles. This growth mechanism differs significantly from dicot trees. Instead of forming continuous growth rings, D. cinnabari produces scattered vascular strands in its secondary tissue. This unique structure provides the necessary support for its broad crown while being efficient in its harsh, resource-limited environment.
an aromatic aldehyde + NADPH + H+ The two substrates of this enzyme are an aromatic alcohol and oxidised nicotinamide adenine dinucleotide phosphate (NADP+). Its products are the corresponding aromatic aldehyde, reduced NADPH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is aryl-alcohol:NADP+ oxidoreductase. Other names in common use include aryl alcohol dehydrogenase (nicotinamide adenine dinucleotide, phosphate), coniferyl alcohol dehydrogenase, NADPH-linked benzaldehyde reductase, and aryl-alcohol dehydrogenase (NADP+).
== Early life == She was born in London to Georgian mother Nino Kvinitadze, daughter of General Giorgi Kvinitadze, and Anglo-Dutch father Peter Claude Holland d'Abo, of a landed gentry family of West Wratting, Cambridgeshire. Maryam d'Abo was raised in Paris and Geneva. D’Abo was drawing from the age of eight, but by 13 she wanted to become an actress; she joined an amateur theatre company while at school in Geneva. She decided to do a foundation course at the London College of Printing at 18, but she abandoned those studies in order to go to drama school at Drama Centre London. She left after one term in order to make her film debut.
Sources: en.wikipedia.org
== Contemporary views == While Pan-Slavism remains popular in moderate and extremist political circles, its popularity subsided in the public. After the failure of Yugoslavism and Czechoslovakism, nationalism in Slavic nations now focus on self-definition and non-ethnic relations (like Hungary and Poland). The Russo-Ukrainian War had a divisive role, and pro-Russian sentiment became less popular. Tensions also rose on the Ukrainian side, and for economic reasons Ukrainian grain exports were banned for a time in multiple Slavic countries such as Poland and Slovakia, after the protest of farmers in multiple European countries.
=== Absorption and excretion === Doxycycline is almost completely absorbed from the stomach and upper part of the small intestine (duodenum and jejunum). It reaches highest concentrations in the blood plasma after one to two hours and has a high plasma protein binding rate of about 80–90%. Doxycycline penetrates into almost all tissues and body fluids. High concentrations are found in the gallbladder, liver, kidneys, lungs, breast milk, bones, and genitals; low concentrations are found in saliva, aqueous humor, cerebrospinal fluid (CSF), and especially in inflamed meninges. By comparison, the tetracycline antibiotic minocycline penetrates significantly better into the CSF and meninges. Doxycycline metabolism (breakdown by the body) is negligible. The drug is actively excreted into the gut (in part via the gallbladder, in part directly from blood vessels), where some of it is inactivated by forming chelates. About 40% are eliminated via the kidneys, much less in people with end-stage kidney disease. The biological half-life is 18 to 22 hours (16 ± 6 hours according to another source) in healthy people, slightly longer in those with end-stage kidney disease, and significantly longer in those with liver disease.
Thus, in Russia tianeptine (sold under the brand name "Coaxil") is a schedule III controlled substance in the same list as the majority of benzodiazepines and barbiturates. The Centers for Disease Control and Prevention (CDC) has expressed concern that tianeptine may be an "emerging public health risk", citing an increase in exposure-related calls to poison control centers in the United States. Sold retail as a dietary supplement and touted as a mood-booster and an aid for concentration, it is colloquially known as "gas-station heroin". In the United States, it is an unregulated drug sold under several product names and has been found to be adulterated with synthetic cannabinoid receptor agonists (SCRAs) or other drugs. A literature review conducted in 2018 found 25 articles involving 65 patients with tianeptine abuse or dependence. Limited data showed that a majority of patients were male and that age ranged from 19 to 67. Routes of intake included oral, intravenous, and insufflation entry. In the 15 cases of overdose, 8 combined ingestion with at least one other substance, of which 3 resulted in death. Six additional deaths are reported involving tianeptine (making 9 in total). In this report, the amount of tianeptine used ranged from 50 mg/day to 10 g/day orally.
=== Transportation === On April 10, 2019, Premier Ford and Minister Yurek announced Ontario's transit plan for the Greater Toronto Area (GTA)—one of the largest metropolitan areas in Canada. The $30 billion dollar project would include the $10.9 billion Ontario Line, the $5.5 billion Scarborough subway extension, the $5.6 billion Yonge North subway extension to Richmond Hill, and the $4.7 billion Eglinton West extension. The province would provide $11.2 billion in funding and "wants to own the lines but leave the city and TTC to operate the subway system." Premier Ford said, "We are making the biggest and largest investment in new subways in Canadian history." The City of Toronto had already spent $224 million of public money on its own "planning and design of transit infrastructure in Toronto." The City raised concerns about delays considering the city manager—Chris Murray's "sweeping" April 16 transit expansion report, "which also suggests several projects may now be in limbo, including two Scarborough transit lines and Mayor John Tory's signature SmartTrack plan." In a December 13, 2018, City Council meeting, Toronto Transit Commission (TTC) CEO Rick Leary, said that he had not had any "direct negotiations or discussion" with the province on what "it would look like if the province uploaded the subway system"—bringing the "TTC's subway system under provincial ownership". While there were clear financial benefits to the city, the council voted to "reaffirm their desire to keep the entire TTC — subways and all" and requested more clarity from the province.
Sources: en.wikipedia.org
Sealed, dry and protected from light at reduced temperature is the usual laboratory convention. Allowing a cold vial to reach room temperature before opening limits condensation. Repeated opening exposes the powder to moisture and should be minimised.
Reported purity reflects the batch tested, the chromatographic method used and whether an independent laboratory performed the work. Values quoted without method detail or a traceable certificate are difficult to compare directly.
Short peptides are rapidly broken down by proteases and appear at low concentrations in urine, so the detection window is narrow. Sensitive extraction combined with tandem mass spectrometry is typically required.
No. Thymosin beta-4 is a 43-residue natural peptide, while TB-500 is a commercial label applied to a short synthetic fragment of it. The two differ in length, sequence coverage and how they are handled in the laboratory.